Postdoc in Neural Decoding and Closed-Loop neuromodulation for Neurodegenerative Disorders | |
| Workplace | Lausanne - Lake Geneva region - Switzerland |
| Category | Life Sciences | Health |
| Position | Senior Scientist / Postdoc |
| Published | 31 March 2026 |
| EPFL, the Swiss Federal Institute of Technology in Lausanne, is one of the most dynamic university campuses in Europe and ranks among the top 20 universities worldwide. The EPFL employs more than 6,500 people supporting the three main missions of the institutions: education, research and innovation. The EPFL campus offers an exceptional working environment at the heart of a community of more than 18,500 people, including over 14,000 students and 4,000 researchers from more than 120 different countries. Postdoc in Neural Decoding and Closed-Loop neuromodulation for Neurodegenerative Disorders MissionWe are seeking a highly motivated postdoctoral researcher to develop next-generation neural decoding frameworks for multimodal motor and neural data in patients with movement disorders. The project focuses on leveraging state-of-the-art machine learning approaches to predict and quantify changes in motor and cognitive function, while integrating electrophysiology (e.g., LFP, EEG) with wearable sensing for real-world, unconstrained monitoring. The successful candidate will contribute to both methodological innovation and clinical translation, working closely with patients, clinicians, and a multidisciplinary research team.Who we areThe SPARK laboratory for Adaptive Neuromodulation at École Polytechnique Fédérale de Lausanne (EPFL) and at the University Hospital Lausanne (CHUV) is developing next-generation closed loop neuromodulation therapies to restore mobility in patients with Parkinson’s disease and related disorders.Our research combines engineering, neuroscience, and clinical translation to address three core objectives: (i) to comprehensively characterize mobility deficits across time, disease stages, and patient phenotypes; (ii) to uncover the neural mechanisms underlying gait and balance impairments; and (iii) to design predictive algorithms that adaptively trigger and regulate stimulation in real time. Embedded within the Neuro-X Institute at EPFL and the NeuroRestore Center at CHUV-UNIL-EPFL, the lab benefits from a uniquely translational ecosystem spanning neurosurgery (Prof. J. Bloch, Prof. J. Squair), neurology (Dr. J. Bally), neuroscience (Prof. G. Courtine, Prof. M. Anderson), and neuroengineering (Prof. H. Lorach). This environment fosters close partnerships with MedTech companies such as Medtronic and ONWARD Medical to accelerate clinical translation. Over the past decade, our team has established a unique experimental platform combining high-resolution whole-body kinematics, muscle activity recordings, and large-scale neural signals (subcortical and cortical recordings). This integrated approach enables the development of personalized, activity-dependent therapies across neurological conditions, including Parkinson’s disease, spinal cord injury, and stroke. EPFL provides a world-class environment in engineering, computation and neuroscience, enabling the develop-ment of advanced algorithms and real-time systems for real-world deployment. These capabilities are tightly integrated with CHUV’s clinical infrastructure, one of Switzerland’s five university hospitals and the only center in the French-speaking region performing deep brain stimulation for movement disorders. The position will be based at Campus Biotech in Geneva and will involve regular interactions with EPFL and CHUV teams in Lausanne. Main duties and responsibilities
Profile
We offer
InformationsOnly applications submitted through the online platform are considered. You are asked to supply:
For any further information, please contact: Prof. Dr. Eduardo M. Moraud ( eduardo.moraud@ epfl.ch ) Contract Start Date : 08/01/2026 Activity Rate :100.00 Contract Type:CDD Duration: 1 year, renewable Reference: 2163 | |
| | |
| In your application, please refer to myScience.ch and referenceJobID69575. | |